Last: | $8.65 |
---|---|
Change Percent: | 0.7% |
Open: | $8.55 |
Close: | $8.65 |
High: | $8.69 |
Low: | $8.25 |
Volume: | 693,819 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.65 | $8.55 | $8.65 | $8.69 | $8.25 | 693,819 | 07-05-2024 |
$8.61 | $8.56 | $8.61 | $8.65 | $8.46 | 275,669 | 07-04-2024 |
$8.61 | $8.56 | $8.61 | $8.65 | $8.46 | 275,669 | 07-03-2024 |
$8.59 | $8.49 | $8.59 | $8.63 | $8.18 | 570,294 | 07-02-2024 |
$8.6 | $9.4 | $8.6 | $9.43 | $8.55 | 762,849 | 07-01-2024 |
$9.51 | $9.64 | $9.51 | $9.85 | $9.385 | 5,844,026 | 06-28-2024 |
$9.64 | $9.29 | $9.64 | $9.66 | $9.22 | 785,431 | 06-27-2024 |
$9.36 | $8.63 | $9.36 | $9.42 | $8.52 | 600,353 | 06-26-2024 |
$8.62 | $8.94 | $8.62 | $8.97 | $8.47 | 560,948 | 06-25-2024 |
$8.77 | $9.37 | $8.77 | $9.4 | $8.74 | 449,621 | 06-24-2024 |
$9.4 | $9.56 | $9.4 | $9.65 | $9.2 | 317,074 | 06-21-2024 |
$9.55 | $10.21 | $9.55 | $10.255 | $9.45 | 510,434 | 06-20-2024 |
$10.21 | $10.17 | $10.21 | $10.46 | $10.12 | 254,615 | 06-19-2024 |
$10.21 | $10.17 | $10.21 | $10.46 | $10.12 | 254,615 | 06-18-2024 |
$10.21 | $10.01 | $10.21 | $10.36 | $9.92 | 274,202 | 06-17-2024 |
$10.05 | $10.46 | $10.05 | $10.5585 | $9.69 | 414,946 | 06-14-2024 |
$10.54 | $10.39 | $10.54 | $10.58 | $10.2101 | 240,248 | 06-13-2024 |
$10.45 | $10.5 | $10.45 | $10.7764 | $10.4 | 334,552 | 06-12-2024 |
$10.28 | $10.14 | $10.28 | $10.35 | $9.94 | 407,598 | 06-11-2024 |
$10.25 | $10.28 | $10.25 | $10.81 | $10.23 | 388,155 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Orion Group Holdings Inc. Common Company Name:
ORN Stock Symbol:
NYSE Market:
Orion Group Holdings Inc. Common Website:
All resolutions were approved Additional resolution to increase capital for up to 100 million euros approved 42.6867% of the issued shares represented MADRID and CAMBRIDGE, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a c...
Selected for oral presentation Conference will be held in Milan on September 21-23 MADRID and CAMBRIDGE, Mass., June 26, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop th...
HOUSTON, June 24, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”, “Orion”), a leading specialty construction company, today announced three contract awards, two in its Concrete segment and one in its Marine segment. Each of the three pro...